| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | Chief Operating Officer | Chief Operating Officer
1 company
Tessari Eben is a Chief Strategy Officer at KNSA. Recent filings cover 0 purchases and 34 sales. Those positions are worth an estimated $1.1M at current prices.
Our model assigns Tessari Eben a below-average insider score of 32/100, based on 27 past trades. Over a 12-month horizon, 5.9% of those trades were profitable, with an average 12-month return of -75.4%.
Tessari Eben's largest disclosed position is in KNSA as Chief Strategy Officer, worth about $1.1M. The recent filings there lean toward selling, a net 628,733 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 18,900 | $28.72 | $542,808.00 | -27.8% | +28.6% | +115.2% | |
| Jun 16, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 17,300 | $28.28 | $489,244.00 | -21.9% | +28.7% | +84.1% | |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 70,867 | $30.48 | $2,160,035.40 | -49.5% | +22.0% | +70.7% | |
| May 19, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 12,000 | $26.41 | $316,920.00 | -14.2% | +26.1% | +99.5% | |
| Apr 14, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 12,000 | $20.48 | $245,811.55 | -13.4% | +39.2% | +127.5% | |
| Mar 10, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 12,409 | $21.06 | $261,333.54 | -13.9% | +45.4% | +125.4% | |
| Feb 10, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 14,000 | $19.57 | $273,980.00 | -14.6% | +36.9% | +128.1% | |
| Jan 13, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 14,000 | $18.24 | $255,413.15 | -13.6% | +13.9% | +112.4% | |
| Dec 16, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 23,017 | $20.44 | $470,467.48 | -19.3% | +13.0% | +103.6% | |
| Nov 18, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 17,000 | $21.04 | $357,680.00 | -14.2% | -9.1% | +92.0% |